Prevalência e fatores associados de videotoracoscopia em pacientes pediátricos com pneumonia e derrame pleural parapneumônico após o tratamento com alteplase em um hospital pediátrico do sul do Brasil
Carregando...
Data
2024-06
Tipo de documento
Artigo Científico
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Modalidade de acesso
Acesso embargado
Editora
Autores
MAZZUCO, Amanda
GRASSI, Thaís
Orientador
NAZÁRIO, Nazaré Otília
Coorientador
CAMACHO, Johny Grechi
Resumo
O objetivo do atual estudo foi identificar a prevalência e os fatores associados a Videotoracoscopia em pacientes pediátricos com Pneumonia e Derrame Pleural Parapneumônico após o tratamento com Alteplase, no período entre 2021 e 2023. Estudo transversal que incluiu dados de 75 pacientes pediátricos, obtidos em prontuários eletrônicos do Hospital Infantil Joana de Gusmão, sendo coletadas as variáveis: idade, sexo, comorbidades, doses de Alteplase, tempo de dreno, ocorrência de videotoracoscopia e efeitos adversos. Foi realizada análise estatística descritiva e inferencial (teste U de Mann-Whitney e Teste qui-quadrado) com nível de significância de p <0,05. Foram 75 internações, média de idade de 42 meses (0 a 168 meses) e 61,0% do sexo masculino. Prevalência de videotoracoscopia de 25,3%, 73,0% do sexo masculino, maior na faixa etária de 25 a 48 meses. Dos pacientes inseridos na pesquisa, 27 (36,0%) possuíam alguma comorbidade, 6 (22,2%) foram submetidos à VATS. A dose média de Alteplase foi 2,02; o tempo de internação 13,19; e o tempo de dreno 10,97 dias. Efeitos colaterais ocorreram em 65,0% dos pacientes. A prevalência de videotoracoscopia em pacientes pediátricos com pneumonia com derrame pleural parapneumônico após o tratamento com alteplase foi de 25,0%.
The objective of the current study was to identify the prevalence and factors associated with Videothoracoscopy in pediatric patients with Pneumonia and Parapneumonic Pleural Effusion after treatment with Alteplase in the period between the years 2021 and 2023. The cross-sectional study was carried out that included data from 75 pediatric patients, obtained from electronic medical records of the Joana de Gusmão Children's Hospital, and the following variables were collected: age, gender, comorbidities, doses of Alteplase, drain time, occurrence of video-assisted thoracoscopy and adverse effects. Descriptive and inferential statistical analysis (Mann-Whitney U test and chi-square test) was performed, with a significance level of p <0.05. There were 75 hospitalizations, with a mean age of 42 months (0 to 168 months), and 61% were male. Prevalence of video-assisted thoracoscopy was 25.3%, 73.0% were male, and the incidence was higher in the age group of 25 to 48 months. Of the patients included in the study, 27 (36.0%) had some comorbidity, and 6 (22.2%) underwent VATS. The mean dose of Alteplase was 2.02; length of hospital stay 13.19; and the drain time was 10.97 days. Adverse reactions occurred in 65.0% of patients. The prevalence of videothoracoscopy in pediatric patients with pneumonia with parapneumonic pleural effusion after alteplase treatment was 25.0%.
The objective of the current study was to identify the prevalence and factors associated with Videothoracoscopy in pediatric patients with Pneumonia and Parapneumonic Pleural Effusion after treatment with Alteplase in the period between the years 2021 and 2023. The cross-sectional study was carried out that included data from 75 pediatric patients, obtained from electronic medical records of the Joana de Gusmão Children's Hospital, and the following variables were collected: age, gender, comorbidities, doses of Alteplase, drain time, occurrence of video-assisted thoracoscopy and adverse effects. Descriptive and inferential statistical analysis (Mann-Whitney U test and chi-square test) was performed, with a significance level of p <0.05. There were 75 hospitalizations, with a mean age of 42 months (0 to 168 months), and 61% were male. Prevalence of video-assisted thoracoscopy was 25.3%, 73.0% were male, and the incidence was higher in the age group of 25 to 48 months. Of the patients included in the study, 27 (36.0%) had some comorbidity, and 6 (22.2%) underwent VATS. The mean dose of Alteplase was 2.02; length of hospital stay 13.19; and the drain time was 10.97 days. Adverse reactions occurred in 65.0% of patients. The prevalence of videothoracoscopy in pediatric patients with pneumonia with parapneumonic pleural effusion after alteplase treatment was 25.0%.
Palavras-chave
Pneumonia, Derrame pleural parapneumônico, Alteplase, Videotoracoscopia